We found that the percentages of Tim-3+ CD8 T cells was highly upregulated in tumor-infiltrating T cells compared to the peripheral blood T cells from HCC patients and healthy controls (Fig. 1a). This evidence concerns the gene CD8A and hepatocellular carcinoma.